I am a little surprised that Eltoprazine IND was not PR'd.(versus stated in an 8k)..its really important news. Between the ESS news closeout..and the IND...this justifies the increase in volume lately.
It will take a lot of volume to absorb the overhead up through $.10...but it will be broken and the stock is back in an uptrend. And I believe tomorrow will be the day it breaks above $.085.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links